Bio-Techne Corporation Stock price

Equities

TECH

US09073M1045

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2023-12-08 EST Intraday chart for Bio-Techne Corporation 5-day change 1st Jan Change
68.31 USD +0.38% +5.79% -17.58%
Sales 2024 * 1.18B 1.6B Sales 2025 * 1.3B 1.76B Capitalization 10.8B 14.68B
Net income 2024 * 216M 293M Net income 2025 * 258M 351M EV / Sales 2024 *
9,26x
Net Debt 2024 * 78.32M 106M Net cash position 2025 * 22.94M 31.17M EV / Sales 2025 *
8,31x
P/E ratio 2024 *
49,1x
P/E ratio 2025 *
41,1x
Employees 3,050
Yield 2024 *
0,47%
Yield 2025 *
0,47%
Free-Float 98.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.38%
1 week+5.79%
Current month+8.60%
1 month+16.43%
3 months-4.89%
6 months-13.85%
Current year-17.58%
More quotes
1 week
63.52
Extreme 63.52
69.49
1 month
55.63
Extreme 55.63
69.49
Current year
51.79
Extreme 51.79
89.91
1 year
51.79
Extreme 51.79
89.91
3 years
51.79
Extreme 51.79
135.96
5 years
33.19
Extreme 33.1875
135.96
10 years
19.99
Extreme 19.9875
135.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 2013
Director of Finance/CFO 52 2014
Chief Operating Officer 56 2018
Members of the board TitleAgeSince
Chairman 67 2002
Chief Executive Officer 62 2013
Director/Board Member 73 1989
More insiders
Date Price Change Volume
23-12-08 68.31 +0.38% 1,229,200
23-12-07 68.05 +3.04% 1,023,212
23-12-06 66.04 +2.58% 1,145,764
23-12-05 64.38 -1.41% 926,221
23-12-04 65.3 +1.13% 1,076,441

Delayed Quote Nasdaq, December 08, 2023 at 04:00 pm

More quotes
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (74.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (25.7%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. Net sales are distributed geographically as follows: the United States (56.5%), the United Kingdom (4.4%), Europe/Middle East/Africa (19.4%), China (10%), Asia/Pacific (6.4%), and other (3.3%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
68.31USD
Average target price
77.87USD
Spread / Average Target
+13.99%
Consensus
  1. Stock
  2. Equities
  3. Stock Bio-Techne Corporation - Nasdaq
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer